Cisplatin
NDC 63323-103, CISPLATIN, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-103
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074735
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISPLATIN1 mg/mL
Pharmacologic classes
Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-103-51 | 63323010351 | 1 VIAL in 1 CARTON (63323-103-51) / 50 mL in 1 VIAL |
| 63323-103-64 | 63323010364 | 1 VIAL in 1 CARTON (63323-103-64) / 200 mL in 1 VIAL |
| 63323-103-65 | 63323010365 | 1 VIAL in 1 CARTON (63323-103-65) / 100 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/de6302d5-85f0-4116-a709-57826c2c84feMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-103
Use it
Look up 63323-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.